Dr. Raed Al-Dallow, MD

Dr. Al-Dallow practices at SIH Memorial Hospital of Carbondale in Carbondale, Illinois, part of Southern Illinois Healthcare.

Dr. Al-Dallow's NPI, 1164572095, was assigned on January 11, 2007. Dr. Al-Dallow graduated from Damascus University Faculty of Medicine in 1997. Dr. Al-Dallow holds Illinois license 036106632.

Dr. Al-Dallow's primary practice is SIH Memorial Hospital of Carbondale, at 405 W Jackson, Carbondale, IL 62901 in Jackson County. The practice phone is (618) 549-0721.

Dr. Al-Dallow's primary practice is SIH Memorial Hospital of Carbondale in Carbondale, Illinois, part of Southern Illinois Healthcare. Dr. Al-Dallow is also affiliated with SIH Herrin Hospital. The medical group on file is Southern Illinois Healthcare (SIH). Dmand AI also links Dr. Al-Dallow to 3 more hospitals, 6 medical groups, 4 group practices and clinics and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Dallow practices, 10 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Al-Dallow's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Al-Dallow is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Al-Dallow is licensed in Illinois.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and leg revascularization among the conditions Dr. Al-Dallow treats.

CMS data shows 6,295 Medicare services from Dr. Al-Dallow across 44 procedure codes in 2024, for 2,849 Medicare patients. Medicare paid $251,242 for them.

CMS counts 2,849 Medicare patients who saw Dr. Al-Dallow in 2024. The largest group is 65 to 74, with 1,043 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Dallow's median patient age at 72, with 50% women.

In 2024, Dr. Al-Dallow wrote 5,160 Medicare Part D claims for 756 patients. 85% of them were for generic drugs. CMS names the drug for 4,862 of them, across 46 drugs with 11 or more claims each, at $694,627 in total drug cost. In 2023, CMS named 4,269 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Al-Dallow for performance year 2024, reported through an alternative payment model (APM). Dr. Al-Dallow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of coronary angioplasty and stenting by Dr. Al-Dallow, more than 67% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Al-Dallow in 2017. Dr. Al-Dallow's most frequent co-authors are Zvonimir Krajcer, MD, Larry Miller, DO and Mohammed Mahmoud Moursi, MD.

CMS Open Payments shows 451 general payments to Dr. Al-Dallow from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $45,064.

Dmand AI lists 2 awards for Dr. Al-Dallow.

Dr. Al-Dallow graduated from Damascus University Faculty of Medicine in 1997. Dr. Al-Dallow is a member of ACC.

Dr. Al-Dallow is in network with 11 carriers, including Aetna, HCSC and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.